Edition:
United States

Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

32.19CAD
4:00pm EDT
Change (% chg)

$-0.02 (-0.06%)
Prev Close
$32.21
Open
$32.02
Day's High
$32.84
Day's Low
$32.02
Volume
617,751
Avg. Vol
897,457
52-wk High
$36.02
52-wk Low
$14.01

Chart for

About

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology... (more)

Overall

Beta: -0.48
Market Cap(Mil.): $8,720.74
Shares Outstanding(Mil.): 349.61
Dividend: --
Yield (%): --

Financials

  BHC.TO Industry Sector
P/E (TTM): -- 30.48 32.69
EPS (TTM): -7.45 -- --
ROI: -7.75 13.04 12.72
ROE: -70.69 14.99 14.85

Tesla, Musk sought to 'burn' Citron, other short-sellers - lawsuit

The prominent short-seller Andrew Left has sued Tesla Inc and its Chief Executive Elon Musk, saying Musk fraudulently engineered his since-abandoned plan to take Tesla private to "burn" investors hoping the electric car company's stock price would fall. | Video

Sep 06 2018

Tesla, Musk sought to 'burn' Citron, other short-sellers: lawsuit

The prominent short-seller Andrew Left has sued Tesla Inc and its Chief Executive Elon Musk, saying Musk fraudulently engineered his since-abandoned plan to take Tesla private to "burn" investors hoping the electric car company's stock price would fall. | Video

Sep 06 2018

RPT-UPDATE 2-Tesla, Musk sought to 'burn' Citron, other short-sellers -lawsuit

Sept 6 The prominent short-seller Andrew Left has sued Tesla Inc and its Chief Executive Elon Musk, saying Musk fraudulently engineered his since-abandoned plan to take Tesla private to "burn" investors hoping the electric car company's stock price would fall.

Sep 06 2018

UPDATE 2-Bausch Health beats profit estimates, promises to cut debt

* Toronto shares rise 6 pct; New York shares 7.5 pct (Adds details from conference call, analyst comment, updates share price)

Aug 07 2018

Competitors

Earnings vs. Estimates